About the Authors
- Alan Engelman
-
* E-mail: alan_engelman@dfci.harvard.edu (AE); p.cherepanov@imperial.ac.uk (PC)
Affiliation Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, Massachusetts, United States of America
- Peter Cherepanov
-
* E-mail: alan_engelman@dfci.harvard.edu (AE); p.cherepanov@imperial.ac.uk (PC)
Affiliation Division of Medicine, Imperial College London, St. Mary's Campus, London, United Kingdom
Competing Interests
The authors have declared that no competing interests exist.